Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » New Faculty to Study Molecular Mechanisms of Disease
Campus News

New Faculty to Study Molecular Mechanisms of Disease

By Nora DunneSep 17, 2015
Share
Facebook Twitter Email
Foltz-Ntziachristos-Mendillo
Dan Foltz, ’02 PhD, associate professor, Panagiotis Ntziachristos, PhD, assistant professor, and Marc Mendillo, PhD, assistant professor, have all joined the Department of Biochemistry and Molecular Genetics.

Three new faculty members have joined Biochemistry and Molecular Genetics to move the department’s mission of understanding the molecular mechanisms of disease forward.

Dan Foltz, ’02 PhD, an associate professor who started this July, is a graduate of Feinberg’s Integrated Graduate Program, now the Driskill Graduate Program in Life Sciences. His research focuses on a region along the chromosome called the centromere that controls chromosome segregation during cell division. When this process goes wrong, cells may end up with too many or too few chromosomes – a hallmark of most cancers. He completed a postdoctoral fellowship at the Ludwig Institute for Cancer Research in San Diego and most recently led a laboratory at the University of Virginia. Foltz’s studies are currently supported by two major grants from the National Institutes of Health (NIH).

Panagiotis Ntziachristos, PhD, joined the Feinberg faculty this September as an assistant professor in the department. He studies the epigenetics of cancer, specifically how oncogenic proteins orchestrate aberrant gene expression in aggressive forms of T-cell acute lymphoblastic leukemia. The goal of his work is to explain how cancer cells differ from other cells to help inform future targeted therapies. He earned his doctorate at the University of Athens and finished a postdoctoral fellowship at New York University. Ntziachristos’ studies are currently funded by K99/R00 funding from the NIH’s National Cancer Institute (NCI) and by the American Society of Hematology.

Marc Mendillo, PhD, who also started this September as an assistant professor, investigates how cellular stress response networks are co-opted and perturbed in pathological conditions. While completing a postdoctoral fellowship at the Massachusetts Institute of Technology, he focused on the master transcriptional regulator of heat shock response and the role it plays in cancer. He received his doctorate at the University of California, San Diego, and completed an additional postdoctoral fellowship at the Ludwig Institute for Cancer Research. Mendillo’s studies are also funded by K99/R00 funding from the NCI.

“Ali’s vision for the Department of Biochemistry and Molecular Genetics is one that is highly innovative and collaborative,” Foltz said, referring to department chair Ali Shilatifard, PhD. “The hope is to leverage the talents of a group of scientists with disparate but related interests and skills to make a major breakthrough in understanding the relationship of epigenetics, chromatin and disease. I am looking forward to helping make that ideal a reality.”

Biochemistry Epigenetics Faculty
Share. Facebook Twitter Email

Related Posts

Global Health Day Highlights Pandemic, HIV Research

Dec 8, 2023

Pioneering Biochemist Craig Crews Named Winner of 2024 Kimberly Prize

Dec 5, 2023

Investigating Drug Combinations for Heart Failure

Dec 1, 2023

Comments are closed.

Latest News

Evolving Telehealth Research and its Place in Healthcare Delivery 

Dec 8, 2023

Global Health Day Highlights Pandemic, HIV Research

Dec 8, 2023

AI May Spare Breast Cancer Patients Unnecessary Treatments

Dec 7, 2023

Drug Extends Survival in Prostate Cancer with Genetic Mutations  

Dec 6, 2023

Pioneering Biochemist Craig Crews Named Winner of 2024 Kimberly Prize

Dec 5, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
2023-Sim-Open-House_161
2023-Sim-Open-House_127
2023-Sim-Open-House_108
2023-Sim-Open-House_106
2023-Sim-Open-House_118
2023-Sim-Open-House_068
2023-Sim-Open-House_069
2023-Sim-Open-House_027
2023-Sim-Open-House_155
2023-Sim-Open-House_161
2023-Sim-Open-House_127
2023-Sim-Open-House_108

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.